New $17.25M CoreWeave (NASDAQ: CRWV) share sale planned after 10b5-1 trades
Rhea-AI Filing Summary
CoreWeave, Inc. (symbol CRWV) received a Form 144 notice that Michael Intrator intends to sell up to 200,000 shares of CoreWeave common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with a proposed aggregate sale price of $17,250,000.00. The form reports CoreWeave common stock outstanding of 458,871,690 shares. The 200,000 shares to be sold were acquired upon the vesting of Preferred Stock Conversion during the period from February 25, 2019 through April 14, 2023. The filing also lists multiple prior common stock sales over the past three months by Michael Intrator and Omnadora Capital LLC pursuant to Rule 10b5-1 trading plans.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 200,000 shares of common stock
Proposed aggregate sale price: $17,250,000.00
Common stock outstanding: 458,871,690 shares
+3 more
6 metrics
Shares proposed to be sold
200,000 shares of common stock
Amount of CoreWeave common stock covered by Michael Intrator’s Form 144 notice
Proposed aggregate sale price
$17,250,000.00
Estimated total value of the 200,000 shares to be sold under Form 144
Common stock outstanding
458,871,690 shares
CoreWeave common stock outstanding as reported in the Form 144
Recent 10b5-1 sale (example)
200,000 shares for $19,143,020.00
CoreWeave common shares sold on August 18, 2026 in a 10b5-1 sale for Michael Intrator
Another recent 10b5-1 sale (example)
107,692 shares for $10,307,750.55
CoreWeave common shares sold on August 18, 2026 in a 10b5-1 sale for Omnadora Capital LLC
Acquisition period for 200,000 shares
02/25/2019–04/14/2023
Period during which Preferred Stock Conversion vested to yield the 200,000 shares
Key Terms
Rule 144, 10b5-1, Preferred Stock Conversion
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 regulatory
"10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave."
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Preferred Stock Conversion financial
"acquired upon the vesting of Preferred Stock Conversion during the period"
FAQ
What does CoreWeave, Inc. (CRWV) report in this Form 144 filing?
The filing reports that Michael Intrator plans to sell up to 200,000 CoreWeave common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with a proposed aggregate sale price of $17,250,000.00, under the resale provisions of Rule 144.
What is the reported outstanding common stock of CoreWeave (CRWV) in this notice?
The Form 144 reports that CoreWeave has 458,871,690 shares of common stock outstanding. This figure provides context for the relative size of the 200,000-share proposed sale.
Does the CoreWeave (CRWV) Form 144 show recent 10b5-1 sales?
Yes. The filing lists multiple recent sales of CoreWeave common stock by Michael Intrator and Omnadora Capital LLC during May–August 2026, each labeled as 10b5-1 Sales under pre-arranged trading plans.
What is one example of recent CoreWeave (CRWV) stock sales disclosed for Michael Intrator?
On August 18, 2026, a transaction labeled “10b5-1 Sales for MICHAEL INTRATOR” shows a sale of 200,000 CoreWeave common shares for total proceeds of $19,143,020.00.
AI-generated analysis. How Rhea-AI works. Not financial advice.